Share-based Payment Arrangement, Expense of Sionna Therapeutics, Inc. from 31 Mar 2024 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Sionna Therapeutics, Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Mar 2024 to 31 Dec 2025.
  • Sionna Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending 31 Dec 2025 was $3,826,000, a 260% increase year-over-year.
  • Sionna Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 31 Dec 2025 was $12,066,000, a 225% increase year-over-year.
  • Sionna Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2025 was $12,066,000, a 225% increase from 2024.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Sionna Therapeutics, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $12,066,000 $3,826,000 +$2,762,000 +260% 01 Oct 2025 31 Dec 2025 10-K 02 Mar 2026 2025 FY
Q3 2025 $9,304,000 $3,306,000 +$2,280,000 +222% 01 Jul 2025 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 $7,024,000 $2,840,000 +$1,869,000 +192% 01 Apr 2025 30 Jun 2025 10-Q 11 Aug 2025 2025 Q2
Q1 2025 $5,155,000 $2,094,000 +$1,447,000 +224% 01 Jan 2025 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q4 2024 $3,708,000 $1,064,000 01 Oct 2024 31 Dec 2024 10-K 02 Mar 2026 2025 FY
Q3 2024 $1,026,000 01 Jul 2024 30 Sep 2024 10-Q 05 Nov 2025 2025 Q3
Q2 2024 $971,000 01 Apr 2024 30 Jun 2024 10-Q 11 Aug 2025 2025 Q2
Q1 2024 $647,000 01 Jan 2024 31 Mar 2024 10-Q 12 May 2025 2025 Q1

Sionna Therapeutics, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $12,066,000 +$8,358,000 +225% 01 Jan 2025 31 Dec 2025 10-K 02 Mar 2026 2025 FY
2024 $3,708,000 01 Jan 2024 31 Dec 2024 10-K 02 Mar 2026 2025 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.